Kazia Therapeutics
KZIA
7 hedge funds and large institutions have $455K invested in Kazia Therapeutics in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 9 closing their positions.
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
53% less funds holding
Funds holding: 15 → 7 (-8)
73% less capital invested
Capital invested by funds: $1.67M → $455K (-$1.21M)
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$20.7K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$1.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$241K |
| 2 |
Renaissance Technologies
New York
|
-$155K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$130K |
| 4 |
Goldman Sachs
New York
|
-$98K |
| 5 |
Millennium Management
New York
|
-$91K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $413K | -$155K | -239 | -22% |
|
|
2
UBS Group
Zurich,
Switzerland
| $17K | +$20.7K | +32 | +800% |
|
3
Bank of America
Charlotte,
North Carolina
| $10K | – | – | – |
|
4
Morgan Stanley
New York
| $7K | – | – | – |
|
|
MWP
5
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
| $5K | – | – | – |
|
6
Citigroup
New York
| $2K | -$3.89K | -6 | -67% |
|
|
7
Creative Planning
Overland Park,
Kansas
| $1K | +$1.3K | +2 | New |
|
|
8
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$241K | -300 | Closed |
|
|
VKH
9
Virtu KCG Holdings
New York
| – | -$130K | -162 | Closed |
|
|
10
Goldman Sachs
New York
| – | -$98K | -122 | Closed |
|
|
11
Millennium Management
New York
| – | -$91K | -113 | Closed |
|
12
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$56K | -70 | Closed |
|
13
Citadel Advisors
Miami,
Florida
| – | -$49K | -61 | Closed |
|
14
Jane Street
New York
| – | -$44K | -54 | Closed |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| – | -$42K | -52 | Closed |
|
16
Canada Life
Winnipeg,
Manitoba, Canada
| – | -$5K | -6 | Closed |
|
KZIA Hedge Fund Activity: Q3 2015 in Review
7 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q3 2015, worth a combined $455K — down 73% from $1.67M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of KZIA and 1 opened new positions — a net loss of 8 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $20.7K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $241K sold.
- 7 institutional investors held Kazia Therapeutics (KZIA) as of Q3 2015, down from 15 in Q2 2015.
- Funds reported $455K of Kazia Therapeutics stock for Q3 2015, down 73% quarter-over-quarter.
- 1 fund opened new Kazia Therapeutics positions in Q3 2015 and 9 closed out, a net change of -8 holders.
- The largest Kazia Therapeutics buyer in Q3 2015 was UBS Group, an estimated $20.7K added.
- The largest Kazia Therapeutics seller in Q3 2015 was Hudson Bay Capital Management, an estimated $241K sold.
Based on aggregated 13F filings for Q3 2015.